No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
250 |
4. Check minimum number of eventsNone |
250 |
5. Include endpointsNone |
250 |
6. Filter based on genotype QC (FinnGen only) |
226 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 226 | - | 226 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 67.50 | - | 67.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 236
- Matched controls
- 2360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
149.3
127
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
111.5
98
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
1242.0
89.9
82
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
85.8
77
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
83.4
75
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
39.4
78.7
50
16
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
71.6
65
*
JN4AD
NOMESCO Finland
Body CT examination
13.2
62.1
68
70
116
Kela drug reimbursment
Prostate cancer
+∞
61.1
56
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
56.6
52
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
55.4
51
*
KGH10
NOMESCO Finland
Operation for phimosis
13.2
55.2
59
58
KGB00
NOMESCO Finland
Biopsy of penis
331.5
53.5
52
*
130
Kela drug reimbursment
Malignant tumour
+∞
52.0
48
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
47.5
44
*
JN4BD
NOMESCO Finland
Extensive body CT
11.8
45.9
52
55
N48.1
ICD-10 Finland
Balanoposthitis
13.7
44.5
45
40
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
44.2
41
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.1
43.4
62
89
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
41.9
39
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
40.8
38
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
9.8
40.0
52
66
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
37.5
35
*
H02AB02
ATC
dexamethasone; systemic
58.0
37.1
43
9
UKC02
NOMESCO Finland
Cystoscopy
5.7
36.6
98
263
WX402
NOMESCO Finland
General anaesthesia
5.9
36.1
88
217
L02BB03
ATC
bicalutamide; oral
+∞
35.3
33
*
Z51.5
ICD-10 Finland
Palliative care
9.4
32.2
42
53
ZZA00
NOMESCO Finland
Split skin graft
13.6
31.4
31
26
WF002
NOMESCO Finland
Radical radiotherapy
+∞
29.8
28
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.2
29.7
36
41
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
28.7
27
*
Y77
ICPC
Malignant neoplasm prostate
+∞
27.6
26
*
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
25.5
24
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
25.5
24
*
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
24.4
23
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
24.4
23
*
XKD00
NOMESCO Finland
Uroflowmetry
4.0
23.0
93
328
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.1
22.7
86
289
A04AA02
ATC
granisetron; systemic, transdermal
+∞
22.2
21
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
241.4
22.0
22
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.5
21.9
48
104
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
21.8
93
339
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.5
21.5
33
50
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
21.2
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
21.2
20
*
B01AB10
ATC
tinzaparin; parenteral
6.5
21.1
38
68
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
20.1
19
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.1
19
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
20.1
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
20.0
82
288
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
6.4
19.8
36
65
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.9
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.9
17
*
N02AA05
ATC
oxycodone; systemic
3.9
17.1
61
193
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
182.4
16.7
17
*
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
182.4
16.7
17
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.0
16.4
39
90
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
23.0
16.3
23
11
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
15.9
103
471
WZC30
NOMESCO Finland
Teaching
3.9
15.8
55
170
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.3
15.7
34
72
TKD00
NOMESCO Finland
Dilatation of urethra
41.1
15.6
19
5
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
14.7
14
*
KGC10
NOMESCO Finland
Total amputation of penis
+∞
14.7
14
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
14.7
14
*
WX240
NOMESCO Finland
Penis blockade
29.3
14.5
19
7
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.7
13
*
A04AA01
ATC
ondansetron; systemic, rectal
16.3
13.4
21
14
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
12.6
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.6
12
*
L02BB04
ATC
enzalutamide; oral
+∞
12.6
12
*
J01MA02
ATC
ciprofloxacin; systemic
2.7
12.5
117
632
B01AB05
ATC
enoxaparin; parenteral
2.8
12.1
83
382
KDH10
NOMESCO Finland
Meatoplasty of urethra
49.3
12.0
14
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
10.9
11.8
22
22
R33
ICD-10 Finland
Retention of urine
3.3
11.7
52
187
C60
ICD-10 Finland
Malignant neoplasm of penis
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
125.9
11.5
12
*
L03AA02
ATC
filgrastim; parenteral
125.9
11.5
12
*
L03AA13
ATC
pegfilgrastim; parenteral
125.9
11.5
12
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
125.9
11.5
12
*
J01EA01
ATC
trimethoprim; systemic
3.4
11.4
47
161
KGD10
NOMESCO Finland
Destruction of lesion of penis
37.0
11.4
14
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
18.2
11.4
17
10
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
45.6
11.0
13
*
N48.9
ICD-10 Finland
Disorder of penis, unspecified
45.6
11.0
13
*
ZX120
NOMESCO Finland
Intravenous
4.4
10.8
29
73
J01DB01
ATC
cefalexin; oral
3.3
10.7
199
1466
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.8
10.6
20
37
WX320
NOMESCO Finland
Spinalanesthesy
2.7
10.6
75
348
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
10.5
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.8
10.3
34
100
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
10.2
41
138
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
L02BX02
ATC
degarelix; parenteral
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
9.4
9
*
JN4CD
NOMESCO Finland
Very extensive body CT
14.5
9.3
15
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
9.2
45
170
G04BE03
ATC
sildenafil; oral
38.3
9.1
11
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
25.2
9.0
12
5
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
8.9
40
144
N48.8
ICD-10 Finland
Other specified disorders of penis
14.8
8.8
14
10
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
8.8
8.8
18
22
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
52.0
8.7
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.9
8.7
21
33
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
93.3
8.5
9
*
ZXC96
NOMESCO Finland
Robot assisted procedure
93.3
8.5
9
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
8.4
45
178
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.4
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.4
8
*
L02BX03
ATC
abiraterone; oral
+∞
8.4
8
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.4
8
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
8.4
8
*
R31
ICD-10 Finland
Unspecified haematuria
2.8
8.3
46
186
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.4
8.2
16
18
N48.5
ICD-10 Finland
Ulcer of penis
23.0
8.1
11
5
N35.9
ICD-10 Finland
Urethral stricture, unspecified
8.9
8.0
16
19
J01MA12
ATC
levofloxacin; systemic
2.5
7.9
57
263
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.8
7.8
18
40
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
46.5
7.8
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.5
7.6
14
14
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
26.0
7.6
10
*
XJH00
NOMESCO Finland
Transanal ultrasonography
3.4
7.6
29
94
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
7.5
42
170
M05BX04
ATC
denosumab; parenteral
8.1
7.5
16
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
7.5
62
304
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
7.5
25
74
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
14.0
7.5
12
9
ZX090
NOMESCO Finland
Other technic of radiotherapy
82.6
7.5
8
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.8
7.4
15
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.8
7.4
15
18
L02AE03
ATC
goserelin; implant
+∞
7.3
7
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
7.3
7
*
KGW96
NOMESCO Finland
Other operation on penis
+∞
7.3
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
Y78
ICPC
Malign neopl male genital other
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
7.3
39
154
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
7.3
74
397
QBA10
NOMESCO Finland
Incision of skin of trunk
20.8
7.2
10
5
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
6.8
36
141
Z3231
NOMESCO Finland
Registered nurse
2.2
6.6
66
349
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.6
32
120
KC1GB
NOMESCO Finland
Cystography with X-ray
71.7
6.5
7
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
71.7
6.5
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
KGA10
NOMESCO Finland
Incision of prepuce
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
C609, 8086, 3
ICD-O-3
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
8051/3-C60.1
ICD-O-3
Verrucous carcinoma, NOS, of glans penis
+∞
6.3
6
*
L02AE04
ATC
triptorelin; parenteral
+∞
6.3
6
*
ZX112
NOMESCO Finland
Subcutaneous
27.5
6.3
8
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
27.5
6.3
8
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
6.1
35
143
ZXE00
NOMESCO Finland
One hour or less
2.0
6.0
87
529
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
156
738
4.29
25.83
4.1
2.4
—
—
estimate
—
0
0
180
1061
3.94
19.10
7.0
3.9
18.43
367.06
e6/l
—
7
17
90
401
3.01
14.28
3.2
2.1
—
—
—
0
0
182
1316
2.67
9.42
14.2
5.8
84.71
77.50
u/l
1.29
173
1228
136
871
2.32
9.13
10.6
6.6
1.19
1.20
mmol/l
0.62
115
748
72
350
2.52
9.06
2.0
1.9
—
—
—
0
0
29
85
3.75
8.82
2.2
1.7
2.42
2.46
ug/l
0.01
22
75
123
777
2.22
8.27
8.5
3.9
34.17
35.46
g/l
1.83
115
717
90
504
2.27
8.10
4.5
2.7
0.37
0.34
e6/l
0.09
70
368
46
189
2.78
8.03
4.3
3.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
63
3.94
7.67
2.4
2.4
0.26
0.34
iu/ml
0.88
13
31
121
777
2.14
7.61
9.8
6.2
1.19
1.19
mmol/l
0.45
113
703
136
916
2.14
7.53
17.4
6.3
4.35
4.51
e9/l
0.31
123
802
60
294
2.40
7.26
4.5
2.7
0.79
0.50
e6/l
0.51
36
153
60
314
2.22
6.15
4.4
2.6
1.30
0.96
e6/l
0.40
38
174
57
296
2.22
5.93
8.1
6.3
105.26
104.34
mmol/l
1.12
57
296
85
525
1.97
5.54
7.4
2.0
2.35
2.33
mmol/l
0.58
77
444
125
885
1.88
5.33
5.1
3.5
0.00
0.03
estimate
0.50
31
154
123
870
1.86
5.22
5.1
3.5
45.43
0.00
estimate
0.49
35
171
122
861
1.86
5.22
5.1
3.5
0.00
0.00
estimate
-0.00
31
171
76
460
1.96
5.20
4.7
3.0
0.00
0.00
estimate
-0.00
20
125
50
269
2.09
4.70
1.8
1.8
—
—
—
0
0
10
16
6.47
4.34
1.2
1.2
—
—
—
0
0
21
79
2.82
4.29
2.0
1.6
—
—
—
0
0
14
41
3.57
4.25
1.6
1.4
—
—
—
0
0
46
251
2.03
4.14
1.8
1.9
—
—
—
0
0
26
115
2.42
3.88
1.6
1.5
—
—
—
0
0
10
19
5.44
3.87
1.7
1.4
—
—
—
0
0
14
44
3.32
3.84
1.3
1.2
—
—
—
0
0
15
50
3.14
3.76
1.9
1.5
—
—
—
0
0
197
1710
1.92
3.46
33.0
15.3
35.23
28.19
mg/l
1.78
185
1390
18
72
2.62
3.30
1.9
1.5
—
—
—
0
0
6
7
8.75
3.28
1.2
1.6
—
—
—
0
0
6
7
8.75
3.28
1.2
1.6
—
—
—
0
0
93
671
1.64
3.26
5.1
3.6
0.00
0.00
estimate
-0.00
26
136
8
15
5.48
3.22
1.6
1.2
—
—
—
0
0
8
15
5.48
3.22
1.6
1.2
—
—
—
0
0
8
15
5.48
3.22
1.6
1.2
—
—
—
0
0
13
41
3.29
3.11
1.7
1.3
—
—
—
0
0
26
127
2.18
3.11
1.8
1.6
—
—
—
0
0
14
51
2.86
3.04
1.1
1.4
—
—
—
0
0
7
12
5.97
3.04
1.1
1.1
—
—
—
0
0
8
17
4.83
2.94
1.6
1.2
—
—
—
0
0
8
17
4.83
2.94
1.6
1.2
—
—
—
0
0
8
17
4.83
2.94
1.6
1.2
—
—
—
0
0
56
362
1.72
2.94
2.4
1.8
1277.93
1187.82
nmol/l
0.22
45
281
10
27
3.82
2.91
1.9
1.4
—
—
—
0
0
80
572
1.60
2.84
3.6
2.8
29.20
40.75
u/l
2.08
74
534
52
334
1.71
2.79
6.4
2.0
2.50
2.43
mmol/l
2.80
46
288
5
6
8.48
2.76
1.2
1.5
—
—
—
0
0
5
6
8.48
2.76
1.2
1.5
—
—
—
0
0
12
40
3.11
2.74
1.3
1.2
—
—
—
0
0
12
43
2.89
2.69
1.6
1.6
—
0.09
—
0
11
12
41
3.03
2.66
1.4
1.2
—
—
—
0
0
10
33
3.12
2.38
1.1
1.3
—
—
—
0
0
8
22
3.73
2.38
1.9
1.2
—
—
—
0
0
5
8
6.35
2.38
3.0
2.9
201.00
282.50
e6/l
—
5
8
5
8
6.35
2.38
3.4
2.9
346.80
570.63
e6/l
—
5
8
6
13
4.70
2.28
1.7
1.2
—
—
—
0
0
160
1375
1.51
2.25
36.4
18.3
14.25
13.67
%
4.59
160
1353
13
54
2.49
2.24
3.3
1.2
1.31
1.49
ratio
—
6
33
5
9
5.65
2.22
1.2
1.1
—
—
—
0
0
5
9
5.65
2.22
1.2
1.1
—
—
—
0
0
69
504
1.52
2.16
2.4
2.2
3.20
2.82
mg/l
0.56
59
423
5
10
5.08
2.08
3.4
2.1
0.40
0.93
e9/l
—
5
10
10
38
2.70
2.03
1.1
1.2
—
—
—
0
0
186
1666
1.55
2.01
31.8
14.5
76.64
76.51
ml/min/173m2
0.02
178
1549
7
21
3.40
1.98
1.3
1.3
—
165.57
—
0
7
10
39
2.63
1.96
1.0
1.2
—
—
—
0
0
10
39
2.63
1.96
1.0
1.2
—
—
—
0
0
6
16
3.82
1.94
1.7
1.3
—
—
—
0
0
7
23
3.10
1.81
1.1
1.4
—
—
—
0
0
148
1282
1.41
1.79
4.9
4.0
17.52
11.48
mm/h
2.90
138
1185
39
264
1.57
1.70
8.8
7.4
-0.06
0.88
mmol/l
0.62
34
212
10
41
2.50
1.66
1.2
1.5
—
—
—
0
0
66
502
1.44
1.66
5.6
3.5
0.00
0.02
estimate
0.50
27
154
106
876
1.38
1.65
2.3
2.4
—
—
—
0
0
14
70
2.06
1.63
1.1
1.9
—
—
—
0
0
5
14
3.62
1.62
1.4
1.2
—
—
—
0
0
74
578
1.41
1.60
1.8
1.7
16.73
18.13
nmol/l
0.48
66
487
6
20
3.05
1.59
2.2
2.5
—
—
—
0
0
22
131
1.75
1.56
1.8
2.0
28.53
34.11
u/l
0.47
15
106
197
1819
1.50
1.52
17.7
10.2
26.96
28.78
u/l
0.72
187
1750
10
45
2.28
1.48
1.6
1.2
—
—
—
0
0
159
1418
1.37
1.46
8.1
4.2
26.48
1.97
ug/l
0.65
148
1262
54
407
1.42
1.42
4.1
3.9
1.02
1.02
kg/l
0.37
48
259
9
40
2.30
1.41
2.2
1.7
—
—
—
0
0
5
123
0.39
1.41
3.4
2.0
39.40
41.58
nmol/l
—
5
116
7
29
2.46
1.40
2.3
2.6
1.18
1.19
mmol/l
—
7
29
90
743
1.34
1.36
3.8
2.8
224.16
187.26
ug/l
0.42
83
680
15
85
1.82
1.26
2.0
3.9
—
—
—
0
0
22
143
1.59
1.16
8.0
3.9
0.67
2.02
mmol/l
0.95
15
106
5
20
2.53
1.15
1.6
1.6
—
—
—
0
0
16
96
1.72
1.13
4.9
3.3
1.02
1.02
ratio
0.02
16
91
7
31
2.30
1.11
2.3
2.5
105.43
104.94
mmol/l
—
7
31
14
82
1.75
1.07
1.3
1.9
—
—
—
0
0
129
1146
1.28
1.07
4.1
3.4
70.65
56.05
u/l
0.95
121
1071
102
881
1.28
1.06
2.3
2.1
91.72
91.77
pmol/l
0.00
64
502
84
709
1.29
1.04
3.5
3.4
4918.32
1710.26
ng/l
0.99
75
614
5
106
0.46
1.04
1.8
2.0
219.20
221.71
pmol/l
—
5
99
9
48
1.91
1.01
1.9
1.4
—
—
—
0
0
17
109
1.60
0.96
1.2
1.3
1246.18
485.57
u/ml
0.47
17
100
17
109
1.60
0.96
1.4
1.4
—
—
—
0
0
15
228
0.63
0.91
1.9
2.9
9.46
9.19
ug/l
—
10
198
17
239
0.69
0.73
1.1
1.2
0.87
8.63
u/ml
—
7
85
46
377
1.27
0.71
1.4
1.6
1.43
1.22
mg/l
0.24
39
291
63
537
1.24
0.70
3.7
2.7
390.23
383.81
umol/l
0.21
57
471
31
241
1.33
0.70
5.1
5.3
29.32
30.52
%
0.28
22
156
7
41
1.73
0.70
3.7
4.0
62.29
24.58
mg/l
—
7
36
95
850
1.20
0.65
5.0
4.3
38.35
48.60
ng/l
0.60
82
661
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
18
239
0.73
0.57
6.7
7.7
—
—
—
0
0
6
37
1.64
0.56
1.0
1.2
—
—
—
0
0
178
1701
1.19
0.51
5.2
5.5
6.29
6.19
mmol/l
0.50
162
1531
10
141
0.70
0.46
1.5
1.6
—
—
—
0
0
7
50
1.41
0.45
1.7
1.5
—
—
—
0
0
7
50
1.41
0.45
1.4
1.1
1.34
1.43
g/l
—
7
50
7
51
1.38
0.44
1.9
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
684.55
—
0
11
0
16
0.00
0.41
0.0
1.0
—
29.53
—
0
10
76
702
1.12
0.32
2.8
2.3
70.96
74.77
nmol/l
0.67
65
612
17
139
1.24
0.30
3.4
2.0
54.20
63.49
ml/min/173m2
—
5
57
46
414
1.14
0.29
4.4
4.2
288.16
528.44
ng/l
0.51
37
348
86
807
1.10
0.27
3.7
2.9
1.00
0.78
ug/l
0.46
59
524
5
41
1.22
0.22
1.2
1.3
0.92
0.83
nmol/l
—
5
34
13
156
0.82
0.22
1.8
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
30.46
—
0
5
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
38.63
—
0
12
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
23
260
0.87
0.20
1.1
1.2
12.84
28.62
iu/ml
—
5
72
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
28
311
0.89
0.19
1.1
1.3
0.76
1.35
u/ml
—
5
93
173
1761
0.93
0.14
5.4
6.3
2.49
2.51
mmol/l
0.09
155
1621
117
1137
1.06
0.14
6.4
3.9
20.31
24.48
%
2.04
63
534
70
722
0.96
0.08
2.0
2.0
1.72
1.35
mmol/l
2.20
56
600
164
1660
0.96
0.07
4.7
4.6
1.48
1.32
mmol/l
2.14
145
1506
119
1170
1.03
0.07
3.3
3.1
14.55
15.02
pmol/l
1.35
108
1046
77
755
1.03
0.05
4.8
4.3
15.05
10.14
mg/mmol
0.40
55
523
170
1713
0.97
0.04
5.0
5.5
1.24
1.31
mmol/l
1.59
148
1566
170
1687
1.03
0.04
7.1
7.5
41.21
40.83
mmol/mol
0.21
151
1563
11
118
0.93
0.03
3.3
2.3
0.65
0.62
%
0.10
11
118
12
121
0.99
0.00
3.6
2.4
1.19
1.15
%
0.03
12
121
154
1544
0.99
0.00
4.1
4.1
1.93
2.03
mu/l
0.46
136
1378
172
1722
1.00
0.00
5.3
5.6
4.37
4.29
mmol/l
0.41
152
1588
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
74.57
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.36
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
13.17
—
0
6
5
54
0.92
-0.00
1.2
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
13.63
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PENIS_WIDE – Malignant neoplasm of penis, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).